| Personnalisation: | Disponible |
|---|---|
| méthode de désinfection: | stérilisation à l′oxyde d′éthylène |
| durée de conservation: | 2 ans |
|
Vous hésitez encore ? Obtenez des échantillons $ !
Demande d'Échantillon
|
Fournisseurs avec des licences commerciales vérifiées
Fournisseur Audité Audité par une agence d'inspection indépendante
| Specification | Ellanse |
| Place of origin | South Korea |
| Grade | Injection grade |
| Packing | Secure Packing |
We are proud have been the very first clinic to introduce this revolutionary dermal filler. Ellanse is a long lasting dermal filler made available in Ireland back in 2013. Castleknock Cosmetic Clinic Dublin was the first clinic to use it then.
The first and the only Dermal Filler which acts through a process of collagen a bio-stimulation. The results are long lasting from one to four years.
It is the unique dermal filler which offers a safe longevity. The dermal fillers is specifically designed for use by experienced aesthetic doctors with correction results lasting from two to four years. Ellanse is made of Poly-Caprolactone (PCL) and is a well-known biological soft medical polymer.
Ellanse offers the maximum potential for modelling due to the combination of optimum viscosity, unique elasticity and uniform homogeneity. It can be in a variety of aesthetic treatments. At Castleknock Cosmetic Clinic we like using Ellanse in the chin, and the nose as well as cheek enhancement procedures.
Correction of wrinkles and folds
Face Volume Restoration
Facial Contouring
Facial Sculpting
The filler is an administered by injection. It is indicated for deep rather than superficial implantation. A classic location is in the nasolabial folds.
Ellansé is a unique dermal filler. It provides immediate initial enhancement due to the gel element, followed by a process of bio-stimulation. It induces new collagen formation in the injected areas for a period of three months. This new collagen formation the reason for longer-lasting and durable results.
Due to the filler's optimum viscosity and elasticity, wrinkles and folds undergo immediate physical correction after treatment.
The gel-carrier (suspension medium for microspheres) is gradually resorbed over a period of several weeks.
Ellanse is suitable for both women and men of different ages. The filler can help with deep folds around the chin and nose. Very useful in correcting sunken cheeks, and also great for scars.
It is a non-animal, non-bacterial and non-human derived product. It is a natural biostimulator. The filler stimulates lay down of your own new collagen. It has optimal bio compatibility, due to very smooth microspheres. It is predictable with an excellent safety profile. Unique longevity options for personalized and tailored treatment.
Ellanse is ideal for long lasting lines and wrinkle correction and enhances cheek volume and stimulates collagen in a natural way.
At Castleknock Cosmetic Clinic we love using it restoring jawline contours and volume correction of facial gaunt. It high G-Prime property jawline definition and the non-surgical nose job.
Patients can achieve full face lifting without the need of aggressive surgery, with the result lasting up to three or four years.
It is different from other fillers, as it gives the desired beautiful aesthetic result that lasts longer than conventional dermal fillers.
Ellanse also offers the advantage over other fillers, as it allows immediate correction and sustained performance from one up to four years.
Ellanse is officially approved by HPRA in Ireland, FDA in the USA and MHRA in the UK. It is sanctioned for restoration and/or correction of the signs of facial fat loss (lipoatrophy) and is used for treating facial lines and wrinkles.
In the experienced hands of Dr Kahlout at Castleknock Cosmetic Clinic Dublin, who received the right training and experience in handling Ellansé, this is a very safe and effective procedure.
Patient satisfaction at twelve months evaluated on the basis of GAIS (Global Aesthetic Improvement Scale) for Ellanse was found to be 90%. Average physician evaluation shows improvement in 92% patients based on GAIS.
